MEDIJEL Oral gel Ref.[28073] Active ingredients: Aminoacridine Lidocaine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: DENDRON BRANDS LIMITED, 94, Rickmansworth Road, Watford, Hertfordshire, WDI8 7JJ, United Kingdom

4.3. Contraindications

Hypersensitivity to the active substances or to any other of the ingredients.

Contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

4.4. Special warnings and precautions for use

If symptoms persist longer than 7 days following the use of the product a doctor or dentist should be consulted. Not suitable for treatment of teething in children.

4.5. Interaction with other medicinal products and other forms of interaction

None stated.

4.6. Pregnancy and lactation

The safety of Medijel Gel during pregnancy and lactation has not been established but is considered not to constitute a hazard.

4.7. Effects on ability to drive and use machines

None stated.

4.8. Undesirable effects

Hypersensitivity reactions to Lidocaine have been reported on rare occasions.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard.

6.2. Incompatibilities

None encountered.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.